Released: December 09, 2013
Why doctors choose a $2,000 drug over a $50 alternative
Source: Peter Whoriskey and Dan Keating - The Washington Post
The two drugs have been declared equivalently miraculous. Tested side by side in six major trials, both prevent blindness in a common old-age affliction. Biologically, they are cousins. They’re even made by the same company.
But one holds a clear price advantage.
Read Full Article: Why doctors choose a $2,000 drug over a $50 alternative